FORM 8-K

Company

GT Biopharma, Inc.

Filed

December 29, 2000

Period of Report

December 14, 2000

Accession Number

0001032210-00-002416

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →